Business Wire28d
Blue Lake Biotechnology Reports Additional Promising Clinical Data from Ongoing Pediatric Clinical Study of Intranasal RSV Vaccine BLB201
PIV5 has been commonly administered to dogs as part of combination distemper/kennel cough vaccines for decades. Blue Lake Biotechnology is developing BLB201 as an intranasal vaccine to prevent ...
LoveToKnow on MSN11mon
Counting the Days: Kennel Cough Duration & How to Help
Kennel cough lasts different amounts of time based on several factors. Find out what's normal and how to help your dog heal ...
Business Wire1mon
First Subject Dosed in Initial Cohort of Phase 2b Clinical Study of CyanVac’s Intranasal COVID-19 Vaccine Candidate
--(BUSINESS WIRE)--CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines using a transformational ... part of combination distemper/kennel cough vaccines for decades.
Miami Herald22d
Whooping cough cases soar 600% despite reliable vaccine, experts say. What’s to blame?
Cases of whooping cough have skyrocketed, and poor vaccine knowledge may be to blame, health officials say. naipo.de via Unsplash Cases of whooping cough have skyrocketed this year, up 600% from ...